Cargando…

Increased Expression of SETDB1 Predicts Poor Prognosis in Multiple Myeloma

Several genes on chromosome 1q21 region predict a high risk of multiple myeloma (MM); however, the underlying molecular pathology remains elusive. Overexpression, amplification, or activation of SET Domain Bifurcated 1 (SETDB1), which is located on 1q21, is closely associated with poor prognosis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Jing, Chen, Xiaotong, Chen, Mengping, Hou, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967582/ https://www.ncbi.nlm.nih.gov/pubmed/35372573 http://dx.doi.org/10.1155/2022/3307873

Ejemplares similares

A Five-Gene Risk Score Model for Predicting the Prognosis of Multiple Myeloma Patients Based on Gene Expression Profiles
por: Chen, Xiaotong, et al.
Publicado: (2021)

Increased Expression of SRSF1 Predicts Poor Prognosis in Multiple Myeloma
por: Zhang, Jiawei, et al.
Publicado: (2023)

High SET Domain Bifurcated 1 (SETDB1) Expression Predicts Poor Prognosis in Breast Carcinoma
por: Zhou, Zhaoping, et al.
Publicado: (2020)

High expression of CHML predicts poor prognosis of multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2019)

Increased expression of miR-27 predicts poor prognosis and promotes tumorigenesis in human multiple myeloma
por: Che, Feifei, et al.
Publicado: (2019)

High expression of UBE2T predicts poor prognosis and survival in multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2019)

PB2080: LOW DUP1 EXPRESSION PREDICTS POOR PROGNOSIS IN MULTIPLE MYELOMA
por: Lu, Jinfeng, et al.
Publicado: (2023)

Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications
por: Chen, Mengping, et al.
Publicado: (2023)

PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
por: Noll, Jacqueline E., et al.
Publicado: (2015)

Distinct mechanisms of dysfunctional antigen‐presenting DCs and monocytes by single‐cell sequencing in multiple myeloma
por: Jiang, Jinxing, et al.
Publicado: (2023)

High expression of SETDB1 mediated by miR-29a-3p associates with poor prognosis and immune invasion in breast invasive carcinoma
por: Chen, Xiatian, et al.
Publicado: (2021)

High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma
por: Wang, Hua, et al.
Publicado: (2016)

Enhanced expression of FCER1G predicts positive prognosis in multiple myeloma
por: Fu, Lin, et al.
Publicado: (2020)

Single‐cell transcriptome profiling reveals the key role of ZNF683 in natural killer cell exhaustion in multiple myeloma
por: Li, Xin, et al.
Publicado: (2022)

Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma
por: Ebert, Lisa M., et al.
Publicado: (2021)

Dynamic single-cell RNA-seq analysis reveals distinct tumor program associated with microenvironmental remodeling and drug sensitivity in multiple myeloma
por: Chen, Mengping, et al.
Publicado: (2023)

SETDB1-Mediated Silencing of Retroelements
por: Fukuda, Kei, et al.
Publicado: (2020)

SETDB1 regulates microtubule dynamics
por: Hernandez‐Vicens, Rosari, et al.
Publicado: (2022)

Dual Negativity of CD56 and CD117 Links to Unfavorable Cytogenetic Abnormalities and Predicts Poor Prognosis in Multiple Myeloma
por: Zheng, Dong, et al.
Publicado: (2022)

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
por: Barwick, Benjamin G., et al.
Publicado: (2019)

SETDB1 induces lenalidomide resistance in multiple myeloma cells via epithelial‑mesenchymal transition and PI3K/AKT pathway activation
por: Qian, Xiaoli, et al.
Publicado: (2023)

Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival
por: Di Lullo, Giulia, et al.
Publicado: (2015)

Overexpression of CIP2A is associated with poor prognosis in multiple myeloma
por: Liu, Xuewen, et al.
Publicado: (2017)

SETDB1 regulates SMAD7 expression for breast cancer metastasis
por: Ryu, Tae Young, et al.
Publicado: (2019)

Cytoplasmic Pin1 expression is increased in human cutaneous melanoma and predicts poor prognosis
por: Chen, Xin, et al.
Publicado: (2018)

Increased MCL-1 expression predicts poor prognosis and disease recurrence in acute myeloid leukemia
por: Li, Xi-xi, et al.
Publicado: (2019)

Histone methyltransferase SETDB1 is required for prostate cancer cell proliferation, migration and invasion
por: Sun, Yi, et al.
Publicado: (2014)

SETDB1 mediated FosB expression increases the cell proliferation rate during anticancer drug therapy
por: Na, Han-Heom, et al.
Publicado: (2016)

Histone Methyltransferase SETDB1 Promotes the Progression of Colorectal Cancer by Inhibiting the Expression of TP53
por: Chen, Keli, et al.
Publicado: (2017)

SETDB1 promotes the progression of colorectal cancer via epigenetically silencing p21 expression
por: Cao, Nan, et al.
Publicado: (2020)

Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming
por: Torrano, Joachim, et al.
Publicado: (2019)

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma
por: Walker, Brian A, et al.
Publicado: (2015)

Abnormalities in Chromosomes 1q and 13 Independently Correlate With Factors of Poor Prognosis in Multiple Myeloma
por: Kim, Miyoung, et al.
Publicado: (2016)

Increased Expression of LYNX1 in Ovarian Serous Cystadenocarcinoma Predicts Poor Prognosis
por: Liu, Hui, et al.
Publicado: (2020)

SETDB1 Restrains Endogenous Retrovirus Expression and Antitumor Immunity during Radiotherapy
por: Pan, Dong, et al.
Publicado: (2022)

Drosophila SETDB1 Is Required for Chromosome 4 Silencing
por: Seum, Carole, et al.
Publicado: (2007)

Structure, Activity and Function of the SETDB1 Protein Methyltransferase
por: Markouli, Mariam, et al.
Publicado: (2021)

Hypoxia stabilizes SETDB1 to maintain genome stability
por: Park, Sungryul, et al.
Publicado: (2023)

Maternal Setdb1 Is Required for Meiotic Progression and Preimplantation Development in Mouse
por: Kim, Jeesun, et al.
Publicado: (2016)

TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma
por: Tao, Yi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t8eri121ol7h4jj8av6c2cj8ll